Psychedelic-assisted therapy for death acceptance in terminal illness: A scoping review
Open Access
- 2 September 2026
- journal article
- Published by Akademiai Kiado Zrt. in Journal of Psychedelic Studies
- Vol. 10 (3) , 321-336
Abstract
Background and Aims: Mental health challenges such as depression, anxiety, and existential distress are common among individuals with terminal illness. Preliminary evidence suggests that death acceptance may protect against these issues, but there is limited research on the role of psychedelic-assisted therapy in fostering death acceptance. This scoping review aims to explore the potential of psychedelic-assisted therapy to promote death acceptance among terminally ill patients. Methods: A scoping review was conducted, examining studies published between 1990 and 2023. The review included studies on psychedelic-assisted therapy for death acceptance and closely related constructs, such as psychological flexibility, existential distress, and demoralization in terminally ill populations. Results: Findings indicate that psychedelic-assisted therapy may lead to significant and lasting reductions in anxiety, depression, and existential distress. These improvements appear to be mediated by enhanced death acceptance. The therapy may also increase psychological flexibility and reduce demoralization, supporting better mental health outcomes for terminally ill individuals. Conclusions: Psychedelic-assisted therapy represents a promising approach to improving quality of life for terminally ill patients by fostering acceptance of their prognosis and mortality. However, further research is needed to confirm these findings. The development of standardized measurement tools and consideration of patient demographics, such as age and spiritual beliefs, are recommended.Keywords
This publication has 55 references indexed in Scilit:
- Psychometric properties of the Short‐Form Five Facets of Mindfulness Questionnaire among nursing students in China: A confirmatory factor analysisNursing Open, 2024
- Psilocybin in Palliative Care: An UpdateCurrent Geriatrics Reports, 2023
- Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic reviewPsychopharmacology, 2021
- Existential Approaches and Cognitive Behavior Therapy: Challenges and PotentialInternational Journal of Cognitive Therapy, 2021
- Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot studyeClinicalMedicine, 2020
- Psychedelic Psychiatry’s Brave New WorldCell, 2020
- Ayahuasca’s ‘afterglow’: improved mindfulness and cognitive flexibility in ayahuasca drinkersPsychopharmacology, 2020
- Perceived relatedness, death acceptance, and demoralization in patients with cancerSupportive Care in Cancer, 2019
- Characterizing death acceptance among patients with cancerPsycho-Oncology, 2019
- Refinement and revalidation of the demoralization scale: The DS‐II—internal validityCancer, 2016